Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Partners with the Government of Barbados to advance the treatment of cardiometabolic diseases in individuals of African descent.
February 20, 2025
By: Charlie Sternberg
BioMed X Institute has partnered with the Government of Barbados to advance the treatment of cardiometabolic diseases in individuals of African descent. This initiative, supported by the European Commission’s PharmaNext program, will begin with a two-year pilot project focusing on molecular characterization of patients in Barbados.
Cardiometabolic diseases, including type 2 diabetes, hypertension, obesity, and cardiovascular conditions, continue to rise globally. Individuals of African descent face a significant burden of these diseases, yet they remain significantly underrepresented in clinical research and treatment optimization efforts. According to BioMedX, current clinical trials often fail to include sufficient participants of African descent, limiting the efficacy and safety of new therapies for this important patient group.
The BioMed X Barbados project will tackle this disparity by employing artificial intelligence (AI) and deep molecular characterization techniques. The initiative will conduct an epidemiological study in Barbados, collecting samples and clinical history data from cardiometabolic patients and healthy individuals. The patient samples will be subjected to deep molecular profiling using technologies such as DNA sequencing, proteomic analysis, and flow cytometry. The integration of these datasets with publicly available clinical and molecular data from age- and gender-matched Caucasian subjects, allows BioMed X to develop AI models that will allow the optimization of available cardiometabolic treatment regimens for the Black population. Based on the initial financial support from the Government of Barbados and the European Commission, BioMed X Barbados aims to attract additional funding from global pharmaceutical companies, development banks, and foundations.
“This partnership with the Government of Barbados represents a significant step towards addressing historical inequities in biomedical research and development of new therapies,” said Dr. Christian Tidona, Managing Director of the BioMed X Institute. “Leveraging state-of-the-art molecular techniques and AI enables us to make an impact on the lives of millions of people of African descent, ensuring that they receive the best possible treatments.”
The Government of Barbados is providing strong support for the initiative, recognizing its potential to position Barbados as a leading hub for biomedical research in the Caribbean. Meanwhile, the European Commission’s support through the PharmaNext program further reinforces the importance of international collaboration in tackling global health challenges.
Signed!Two Global Gateway projects with huge potential for Barbados.One agreement with BioMed X for pharmaceutical innovation.And the first green hydrogen storage facility of the Caribbean with @HDF_Energy. pic.twitter.com/xY5PVlH0G3— Ursula von der Leyen (@vonderleyen) February 19, 2025
Signed!Two Global Gateway projects with huge potential for Barbados.One agreement with BioMed X for pharmaceutical innovation.And the first green hydrogen storage facility of the Caribbean with @HDF_Energy. pic.twitter.com/xY5PVlH0G3
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !